These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9278213)

  • 1. The effect of age on plasma MEGX concentrations.
    Orlando R; Palatini P
    Br J Clin Pharmacol; 1997 Aug; 44(2):206-8. PubMed ID: 9278213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans.
    Reichel C; Skodra T; Nacke A; Spengler U; Sauerbruch T
    Br J Clin Pharmacol; 1998 Dec; 46(6):535-9. PubMed ID: 9862241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of liver disease and food on plasma MEGX concentrations.
    Pritchard-Davies R; Gross AS; Shenfield GM
    Br J Clin Pharmacol; 1994 Mar; 37(3):298-301. PubMed ID: 8198941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.
    Zotz RB; von Schönfeld J; Erhard J; Breuer N; Lange R; Beste M; Goebell H; Eigler FW
    Transplantation; 1997 Feb; 63(4):538-41. PubMed ID: 9047147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
    Kupcová V; Turecký L; Szántová M; Schmidtová K
    Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between midazolam and lignocaine pharmacokinetics and MEGX formation in healthy volunteers.
    Swart EL; van der Hoven B; Groeneveld AB; Touw DJ; Danhof M
    Br J Clin Pharmacol; 2002 Feb; 53(2):133-9. PubMed ID: 11851636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The monoethylglycinexylidide test for grading of liver cirrhosis.
    Fabris L; Jemmolo RM; Toffolo G; Paleari D; Viaggi S; Rigon M; Casagrande F; Lirussi F; Strazzabosco M; Cobelli C; Okolicsanyi L
    Aliment Pharmacol Ther; 1999 Jan; 13(1):67-75. PubMed ID: 9892881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat.
    Leclercq I; Saliez A; Wallemacq PE; Horsmans Y; Lambotte L
    Hepatology; 1997 Nov; 26(5):1182-8. PubMed ID: 9362360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrahepatic production of the lignocaine metabolite monoethylglycinexylidide (MEGX).
    Sallie RW; Tredger JM; Williams R
    Biopharm Drug Dispos; 1992 Oct; 13(7):555-8. PubMed ID: 1489946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.
    Orlando R; Piccoli P; De Martin S; Padrini R; Palatini P
    Br J Clin Pharmacol; 2003 Jan; 55(1):86-93. PubMed ID: 12534644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoethylglycinexylidide (MEGX) as a liver function test in cirrhosis.
    Bhise SB; Dias RJ
    Indian J Gastroenterol; 2007; 26(4):167-9. PubMed ID: 17986743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capillary gas chromatographic method for the measurement of small concentrations of monoethylglycinexylidide and lidocaine in plasma.
    Laroche N; Leneveu A; Roux A; Flouvat B
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):375-81. PubMed ID: 9824255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of lidocaine metabolite (monoethylglycinexylidide) as a liver function test].
    Shimanuki K; Suzuki W; Sakurabayashi I; Kiyozaki H; Shinohara K; Soda K; Kai T; Satake M; Miyata M
    Nihon Shokakibyo Gakkai Zasshi; 1993 Jan; 90(1):33-40. PubMed ID: 8433534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 4% topical lidocaine applied to the face on the serum levels of lidocaine and its metabolite, monoethylglycinexylidide.
    Oni G; Brown S; Burrus C; Grant L; Watkins J; Kenkel M; Barton F; Kenkel J
    Aesthet Surg J; 2010; 30(6):853-8. PubMed ID: 21131461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of monoethylglycinexylidide (MEGX) in clinically healthy dogs.
    Neumann S; Frenz M; Streit F; Oellerich M
    Can J Vet Res; 2011 Oct; 75(4):317-20. PubMed ID: 22468031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
    Testa R; Campo N; Caglieris S; Risso D; Alvarez S; Arzani L; Giannini E; Lantieri PB; Celle G
    Hepatogastroenterology; 1998; 45(19):154-9. PubMed ID: 9496506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidocaine metabolite formation as a measure of perioperative liver function.
    Shimanuki K; Sakurabayashi I; Miyata M; Kiyozaki H; Suzuki W; Kashii A; Seo N
    Surg Today; 1993; 23(4):315-9. PubMed ID: 8318785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence polarization immunoassay and HPLC assays compared for measuring monoethylglycinexylidide in liver-transplant patients.
    Chen Y; Potter JM
    Clin Chem; 1992 Dec; 38(12):2426-30. PubMed ID: 1458579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessment of monoethylglycinexylidide as preoperative liver function test in a rat model of liver cirrhosis and man.
    Kaneko H; Otsuka Y; Katagiri M; Maeda T; Tsuchiya M; Tamura A; Ishii T; Takagi S; Shiba T
    Clin Exp Med; 2001 Mar; 1(1):19-26. PubMed ID: 11467398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lidocaine metabolism associated with epidural anesthesia in patients for hepatic surgery].
    Sato T; Ono T; Ozaki M; Sakio H; Yasuda S
    Masui; 1999 Dec; 48(12):1318-22. PubMed ID: 10658411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.